Interleukin-2 (aldesleukin).

DRUG2 trials

Sponsors

Scott B. Snapper, MD PHD, Boston Children's Hospital

Conditions

Crohn DiseaseUlcerative Colitis

Phase 1

Low Dose IL-2 for Ulcerative Colitis

CompletedNCT02200445

Scott B. Snapper, MD PHDUlcerative Colitis

Start: 2015-02-28End: 2021-03-31Updated: 2023-06-15

Low Dose IL-2 for the Treatment of Crohn's Disease

RecruitingNCT04263831

Boston Children's HospitalCrohn Disease

Start: 2021-03-11End: 2027-12-30Target: 30Updated: 2026-08-03